The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSNP.L Regulatory News (SNP)

  • There is currently no data for SNP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

1 Jul 2021 11:36

RNS Number : 8642D
China Petroleum & Chemical Corp
01 July 2021
 

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibilities for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

 

(a joint stock limited company incorporated in the People's Republic of China with limited liability)(Stock Code: 00386)

ESTIMATED INCREASE IN PROFIT FOR THE FIRST HALF OF 2021

This announcement is made pursuant to the Inside Information Provision under Part XIVA of the Securities and Futures Ordinance and Rules 13.09(2) and 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

The Board and all directors of Sinopec Corp. warrant that there are no false representations, misleading statements or material omissions contained in this announcement and severally and jointly accept full responsibility for the authenticity, accuracy and completeness of the information contained herein.

 

Important Notice:

· Under the PRC Accounting Standards for Business Enterprises, the net profit attributable to equity shareholders of the Company for the first half of 2021 is estimated to be between RMB36.5 billion and RMB38.5 billion.

· Under the PRC Accounting Standards for Business Enterprises, the net profit attributable to equity shareholders of the Company excluding extraordinary gains and losses for the first half of 2021 is estimated to be between RMB35.7 billion and RMB37.7 billion.

1. The estimated results for the period

(1) The period of estimated results

From 1 January 2021 to 30 June 2021

(2) The estimated results

According to the preliminary calculation, under the PRC Accounting Standards for Business Enterprises, the net profit attributable to equity shareholders of China Petroleum & Chemical Corporation ("Sinopec Corp." or the "Company") for the first half of 2021 is estimated to be between RMB36.5 billion and RMB38.5 billion, representing a turnaround from loss to profit and an increase between RMB59.4 billion and RMB61.4 billion as compared with the corresponding period in 2020, and representing an estimated increase between 16.6% and 23.0% as compared with the corresponding period of 2019. The net profit attributable to equity shareholders of the Company excluding extraordinary gains and losses for the first half of 2021 is estimated to be between RMB35.7 billion and RMB37.7 billion, representing a turnaround from loss to profit and an increase between RMB60.1 billion and RMB62.1 billion as compared with the corresponding period in 2020, and representing an estimated increase between 17.0% and 23.6% as compared with the corresponding period of 2019.

(3) The above estimated results are not audited by the auditors.

2. Disclosed results for the corresponding periods

Items

First Half of 2020

First Half of 2019

Net profit attributable to equity shareholders of the Company (RMB billion)

-22.9

31.3

Net profit attributable to equity shareholders of the Company excluding extraordinary gains and losses (RMB billion)

-24.4

30.5

Basic earnings per share (RMB)

-0.189

0.259

NoteThe above data have not been adjusted retrospectively.

3. Major reasons for the estimated increase in profit for the period

At the beginning of 2020, due to the dual impact of the COVID-19 epidemic and the plunge in oil prices, the global consumption of petroleum and petrochemical products shrunk sharply, greatly impacting the Company's production and operation and resulting in operating loss in the first half of 2020. In the first half of 2021, the Company's operating performance improved significantly on year-on-year basis, achieving better growth as compared with the corresponding period in 2019. The major reasons are as follows: Since the beginning of the current year, with the global epidemic situation improving in general, the international crude oil prices have appeared upwards trend. The achievements arising from coordination of domestic epidemic prevention and control and economic and social development have continued to be consolidated, and the market demand for petroleum and petrochemical products recovered rapidly. The Company seized the favourable opportunity to reduce procurement costs, optimise production and operation, vigorously expand the market and sales volume, and promote the overall efficiency of the industrial chain. The operation of all our business segments have been greatly improved, thereby achieving good performance.

4. Risk alert

There are no major uncertainties which will affect the accuracy of this estimated result of the Company.

5. Other information

The above estimated data are only based on preliminary calculation. Final financial information in the interim report for the first half of 2021 to be formally published by the Company shall prevail. Investors of the Company are advised to exercise caution when dealing in securities of the Company.

By Order of the Board

China Petroleum & Chemical Corporation

Huang Wensheng

Vice President and Secretary to the Board of Directors

 

Beijing, PRC1 July 2021

As of the date of this announcement, directors of the Company are: Zhang Yuzhuo*, Ma Yongsheng#, Zhao Dong*, Yu Baocai#, Liu Hongbin#, Ling Yiqun#, Li Yonglin#, Cai Hongbin+, Ng, Kar Ling Johnny+, Shi Dan+ and Bi Mingjian+.

 # Executive Director*Non-executive Director+Independent Non-executive Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGGNGMFGMZM
12
Date   Source Headline
28th Oct 202210:14 amRNS3rd Quarter Results
3rd Oct 20227:00 amRNSStatement re Intention to Delist ADSs from the LSE
30th Aug 20227:00 amRNSHalf-year Report
12th Aug 202210:23 amRNSINTENTION TO DELIST ADSs FROM THE NYSE
27th Jun 20229:46 amRNSReport on Payments to Govts
27th Apr 20229:47 amRNS1st Quarter Results
28th Mar 20227:00 amRNSAnnual Financial Report-2
28th Mar 20227:00 amRNSAnnual Financial Report-1
27th Jan 20229:49 amRNSTrading Statement
28th Oct 202110:54 amRNS3rd Quarter Results
31st Aug 20217:00 amRNSHalf-year Report
1st Jul 202111:36 amRNSTrading Statement
16th Jun 20219:46 amRNSReport on Payments to Govts
25th May 202111:31 amRNSResult of AGM
28th Apr 20219:39 amRNS1st Quarter Results
29th Mar 20217:00 amRNSEstimated Increase in Profit for Q1 2021
29th Mar 20217:00 amRNSAnnual Financial Report-part 2
29th Mar 20217:00 amRNSAnnual Financial Report
28th Oct 20208:56 amRNS3rd Quarter Results
1st Sep 20207:00 amRNSHalf-year Report
28th May 20209:46 amRNSReport on Payments to Govts
29th Apr 202010:03 amRNS1st Quarter Results
23rd Apr 202012:38 pmRNSAnnual Financial Report - Part 2
23rd Apr 202012:37 pmRNSAnnual Financial Report - Part 1
30th Mar 20207:00 amRNSFinal Results - Part 2
30th Mar 20207:00 amRNSFinal Results - Part 1
10th Dec 20199:37 amRNSStatement re Restructuring Oil&Gas Pipeline Assets
30th Oct 20199:16 amRNS3rd Quarter Results
27th Aug 20197:00 amRNSHalf-year Report
31st May 20199:36 amRNSReport on Payments to Govts
29th Apr 201911:49 amRNS1st Quarter Results
25th Mar 20198:19 amRNSFinal Results - Part 2
25th Mar 20198:17 amRNSFinal Results - Part 1
25th Jan 20199:21 amRNSProgress Update Announcement
25th Jan 20199:11 amRNSOperational Statistics for 2018
25th Jan 20199:07 amRNSAnnouncement on Preliminary Financial Data of 2018
4th Jan 201910:45 amRNSFurther re ANNOUNCEMENT UNUSUAL PRICE MOVEMENT
27th Dec 20182:19 pmRNSStmnt re Share Price Movement
30th Oct 201812:08 pmRNS3rd Quarter Results
16th Oct 201812:49 pmRNSEstimated Increase in Profit ended 30 Sep. 2018
28th Aug 20187:10 amRNSHalf-year Report
24th Jul 201810:13 amRNSEstimated Increase in Profit for the 1H 2018
13th Jun 201810:58 amRNSReport on Payments to Govts
15th May 20183:04 pmRNSResult of AGM
26th Apr 201811:31 amRNS1st Quarter Results
26th Mar 20187:23 amRNSAnnual Financial Report
30th Oct 201710:38 amRNS3rd Quarter Results
22nd Sep 201711:50 amRNSDirectorate Change
29th Aug 20177:00 amRNSHalf-year Report
30th Jun 201710:48 amRNSReport on Payments to Govts for 2015 and 2016
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.